Clinical Trial Update: Seroquel (Quetiapine Fumarate) InPractice Evaluation Programme

View source ↗

Summary

This ClinicalTrials.gov entry shows that AstraZeneca's Seroquel (quetiapine fumarate) InPractice Evaluation Programme for schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• SEROQUEL (QUETIAPINE)

Snippet

Sponsor: AstraZeneca | Conditions: Schizophrenia | Status: COMPLETED